BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22443181)

  • 1. NF-κB as a target for pancreatic cancer therapy.
    Carbone C; Melisi D
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S1-10. PubMed ID: 22443181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB.
    Bang D; Wilson W; Ryan M; Yeh JJ; Baldwin AS
    Cancer Discov; 2013 Jun; 3(6):690-703. PubMed ID: 23547054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new alpha in line between KRAS and NF-κB activation?
    Pak C; Miyamoto S
    Cancer Discov; 2013 Jun; 3(6):613-5. PubMed ID: 23749528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells.
    Srivastava SK; Singh SV
    Carcinogenesis; 2004 Sep; 25(9):1701-9. PubMed ID: 15117814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
    Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
    Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
    Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
    Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
    Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
    Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
    Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
    Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein-1- and nuclear factor-kappaB-mediated gene expression in airway epithelial cells.
    Zhou L; Tan A; Iasvovskaia S; Li J; Lin A; Hershenson MB
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):762-9. PubMed ID: 12600818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
    Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
    Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
    Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
    Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
    Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-alpha-induced time course-dependent NF-kappaB activity.
    Zuo S; Xue Y; Tang S; Yao J; Du R; Yang P; Chen X
    J Proteome Res; 2010 Jul; 9(7):3465-78. PubMed ID: 20462248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB activity is downregulated by KRAS knockdown in SW620 cells via the RAS-ERK-IκBα pathway.
    Lin G; Tang Z; Ye YB; Chen Q
    Oncol Rep; 2012 May; 27(5):1527-34. PubMed ID: 22327383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
    Zhang Z; Rigas B
    Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.